Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
Ye Wang
, Feng Xie
, Ming Chai Kong
, Lai Heng Lee
, Heng Joo Ng
,
Yu Ko
Research output
:
Contribution to journal
›
Article
›
peer-review
26
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Rivaroxaban
100%
Atrial Fibrillation
100%
Warfarin
100%
Dabigatran
100%
Base
8%